These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8485707)

  • 1. High efficiency gene transfer into primary human tumor explants without cell selection.
    Jaffee EM; Dranoff G; Cohen LK; Hauda KM; Clift S; Marshall FF; Mulligan RC; Pardoll DM
    Cancer Res; 1993 May; 53(10 Suppl):2221-6. PubMed ID: 8485707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials.
    Jaffee EM; Schutte M; Gossett J; Morsberger LA; Adler AJ; Thomas M; Greten TF; Hruban RH; Yeo CJ; Griffin CA
    Cancer J Sci Am; 1998; 4(3):194-203. PubMed ID: 9612602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer.
    Simons JW; Mikhak B; Chang JF; DeMarzo AM; Carducci MA; Lim M; Weber CE; Baccala AA; Goemann MA; Clift SM; Ando DG; Levitsky HI; Cohen LK; Sanda MG; Mulligan RC; Partin AW; Carter HB; Piantadosi S; Marshall FF; Nelson WG
    Cancer Res; 1999 Oct; 59(20):5160-8. PubMed ID: 10537292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and characterization of a rectal cancer model in mice: application to cytokine gene therapy.
    Chen Y; Chang KJ; Hwang LH; Chen CN; Tseng SH
    Int J Colorectal Dis; 2002 Nov; 17(6):388-95. PubMed ID: 12355214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
    Tseng SH; Chen Y; Chang CJ; Tai KF; Lin SM; Hwang LH
    Clin Cancer Res; 2005 Feb; 11(4):1639-49. PubMed ID: 15746069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor models.
    Tüting T; Gambotto A; Baar J; Davis ID; Storkus WJ; Zavodny PJ; Narula S; Tahara H; Robbins PD; Lotze MT
    Gene Ther; 1997 Oct; 4(10):1053-60. PubMed ID: 9415311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
    Ali SA; McLean CS; Boursnell ME; Martin G; Holmes CL; Reeder S; Entwisle C; Blakeley DM; Shields JG; Todryk S; Vile R; Robins RA; Rees RC
    Cancer Res; 2000 Mar; 60(6):1663-70. PubMed ID: 10749137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
    Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
    Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines.
    Withoff S; Glazenburg KL; van Veen ML; Kraak MM; Hospers GA; Störkel S; de Vries EG; Wilschut J; Daemen T
    Gene Ther; 2001 Oct; 8(20):1515-23. PubMed ID: 11704811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically engineered tumor cell vaccine in a head and neck cancer model.
    Couch M; Saunders JK; O'Malley BW; Pardoll D; Jaffee E
    Laryngoscope; 2003 Mar; 113(3):552-6. PubMed ID: 12616213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells genetically engineered to simultaneously express endogenous tumor antigen and granulocyte macrophage colony-stimulating factor elicit potent therapeutic antitumor immunity.
    Nakamura M; Iwahashi M; Nakamori M; Ueda K; Matsuura I; Noguchi K; Yamaue H
    Clin Cancer Res; 2002 Aug; 8(8):2742-9. PubMed ID: 12171908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4.
    Wakimoto H; Abe J; Tsunoda R; Aoyagi M; Hirakawa K; Hamada H
    Cancer Res; 1996 Apr; 56(8):1828-33. PubMed ID: 8620500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-copy bicistronic retroviral vector platform for gene therapy and tissue engineering: application to melanoma vaccine development.
    Wiznerowicz M; Fong AZ; Mackiewicz A; Hawley RG
    Gene Ther; 1997 Oct; 4(10):1061-8. PubMed ID: 9415312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer.
    Kim SH; Carew JF; Kooby DA; Shields J; Entwisle C; Patel S; Shah JP; Fong Y
    Cancer Gene Ther; 2000 Sep; 7(9):1279-85. PubMed ID: 11023201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid adenoviral transduction of freshly resected tumour explants with therapeutically useful genes provides a rationale for genetic immunotherapy for colorectal cancer.
    Diaz RM; Todryk S; Chong H; Hart IR; Sikora K; Dorudi S; Vile RG
    Gene Ther; 1998 Jul; 5(7):869-79. PubMed ID: 9813657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF.
    Shi FS; Weber S; Gan J; Rakhmilevich AL; Mahvi DM
    Cancer Gene Ther; 1999; 6(1):81-8. PubMed ID: 10078967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A feasibility study of gene gun mediated immunotherapy for renal cell carcinoma.
    Seigne J; Turner J; Diaz J; Hackney J; Pow-Sang J; Helal M; Lockhart J; Yu H
    J Urol; 1999 Oct; 162(4):1259-63. PubMed ID: 10492175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
    Kinoshita Y; Kono T; Yasumoto R; Kishimoto T; Wang CY; Haas GP; Nishisaka N
    J Immunother; 2001; 24(3):205-11. PubMed ID: 11394497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete tumor prevention by engineered tumor cell vaccines employing nonviral vectors.
    Moret-Tatay I; Díaz J; Marco FM; Crespo A; Aliño SF
    Cancer Gene Ther; 2003 Dec; 10(12):887-97. PubMed ID: 14712315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of retroviral-mediated gene transfer into primary human stromal cells of Flt3-ligand, interleukin 3 and GM-CSF on production of cord blood progenitor cells in long-term culture.
    Balduini A; Braun SE; Cornetta K; Lyman S; Broxmeyer HE
    Stem Cells; 1998; 16 Suppl 1():37-49. PubMed ID: 11012147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.